IGRT
Intended for radiation oncologists, medical physicists, dosimetrists and nurses interested in VMAT and IGRT training, this one and a half day course is December 5-6 at Swedish Cancer Institute in Seattle, Washington.
The program includes topics such as defining target volumes; clinical implementation; billing issues; quality assurance; various tumor application: thoracic, head and neck, prostate, abdominal, and breast; hypofractionated stereotactic radiotherapy protocols; and patient education.
In addition to the didactic sessions, the course includes a demonstration in real time of CBCT technology. Each participant will receive a manual which will provide additional information for each member of your cancer care team and a CD of PowerPoint presentations.
Upon completion, participants will be able to address:
- Target volumes for IGRT
- Billing
- Coding and reimbursement issues
- Practical aspects of setting up an image-guided radiotherapy program
- The role of IGRT in the treatment of various tumor types
- Research results
To register and view the agenda, visit: http://www.elekta.com/events_detail.php?id=1093
Don’t miss the fall issue of Wavelength, Elekta’s magazine focusing on news and advances in radiation therapy, information management and neuroscience from our customer partners worldwide. This issue discusses the
use of SBRT for inoperable lung tumors; the first sites to implement our new digital control system; IGRT innovations that manage respiratory motion; the frontline role Monaco® with VMAT plays at a cancer center in China; the value of Gamma Knife® surgery for optical pathway tumors—and that’s not all.
On page two, don’t miss an article highlighting the University of Pittsburgh Medical Center’s (UPMC) stereotactic radiosurgery program where clinicians—including spine SRS pioneer Peter C. Gerszten, M.D., M.P.H., Associate Professor of Neurological Surgery and Radiation Oncology—have had remarkable success using Elekta Synergy® S to treat spine and paraspinal lesions. Speaking of top physicians, you may recognize the name of Robert Timmerman, M.D., Professor of Radiation Oncology and Neurosurgery at University of Texas Southwestern Medical Center (page six), a customer who uses Elekta solutions with confidence in Gamma Knife surgery and lung SBRT.
On page 12, it also is our privilege to welcome Macquarie University Hospital (MUH) to the global Gamma Knife community! The first and only center in Australia capable of providing dedicated intracranial radiosurgery, MUH recently treated their first patient, a 33-year-old male with multiple brain tumors, with Leksell Gamma Knife® Perfexion™.
AAPM Elekta Events
New to the Elekta booth is Clarity™, which provides non-invasive soft tissue visualization to support radiation therapy workflows. Clarity compares 3D structures—not images—to provide accurate guidance non-invasively, without additional dose or any compromise to throughput. Demonstrations of the new version of ABAS 2.0 software, which includes the STAPLE algorithm to increase segmentation accuracy, will also be available. ABAS deforms atlases of anatomy previously defined on a reference image onto a new patient image, creating a new structure set fit to the patient anatomy and enhancing planning efficiency.
Representing the latest advance in 4D image guidance, Elekta’s XVI offers intelligent motion management and guidance. Symmetry™ motion management provides imaging tools to manage shifts in the relative positions of the tumor and organs-at-risk during the respiratory cycle. Intuity™ provides critical structure avoidance by accounting more accurately for both the position of the tumor and the healthy critical structures. Symmetry and Intuity demos will be available, and may be scheduled at the reception desk of booth #101. Demos of MOSAIQ® oncology information system, as well as other treatment planning software will also be available.
Before you leave for Philly, don’t forget to register for our complimentary customer events. All Elekta, Elekta Impac Software and Elekta CMS Software users are welcome to attend. To learn more, visit www.elekta.com/aapmevents.
See you in Philadelphia!
BEND, OR — St. Charles Cancer Care recently made another leap forward in the care of cancer patients in the region. With the arrival of the new, state-of-the-art linear accelerator, a machine that uses radiation to treat tumors in cancer patients, the cancer center will continue to provide high quality treatment and care.
“We are excited to have this piece of equipment that offers cutting-edge technology,” said Peggy Carey, St. Charles Cancer Center director. “We have been waiting for the development of this linear accelerator for several years. This piece of equipment marks the cancer center’s next step in advancing ways to better serve our patients as this piece of equipment will allow us to deliver targeted, extremely precise radiation therapy to cancer patients with complex tumors, large and small.”
Linyee Chang, medical director for radiation oncology at the St. Charles Cancer Center, says the new piece of equipment provides much improved images of tumors that will enable physicians to provide precise care to cancer patients.
“The ability to see the tumor in real-time and in three dimensions, will allow us to safely and accurately guide the delivery of radiation to our patients,” Chang said. “This technology expands the repertoire of therapies that we will be able to provide for our patients.”
The new Elekta Infinity linear accelerator will be located on the St. Charles Bend campus in the Cancer Center. The system is the first of its kind to utilize three-dimensional images, by using a pretreatment CT scan to locate and guide treatment. This approach results in targeted, even more precise treatment to the tumor while sparing surrounding tissues.
An expert team of will work diligently over the next six weeks to install and commission the machine. The St. Charles Cancer Center expects to begin treating a patients with the new linear accelerator in late July.
read the entire article here: http://www.mycentraloregon.com/news/local/1209191/New-Technology-Installed-At-St-Charles-Cancer-Center.html
Read More about Elekta Infinity - Comprehensive image-guided radiation therapy (IGRT) system with VMAT
Elekta Infinity - Comprehensive image-guided radiation therapy (IGRT) system with VMAT
If you’re looking to find out more on the latest radiotherapy technologies and novel work-in-progress projects, the show floor of the ASTRO Annual Meeting is always a good place to start. This year was no exception, with Swedish equipment vendor Elekta disclosing its latest endeavour to the public for the first time.
To read this article, please continue to :
http://medicalphysicsweb.org/cws/article/research/40925
(sign-in required)
Elekta's 160 leaf MLC - more leaves, less leakage
Elekta has a YouTube Video Channel : http://www.youtube.com/wearefightingcancer
Click the link or the logo below to go to the Elekta Video Channel to view new, and older, video post, product animations, etc.
Elekta's YouTube Video Channel
Non-Small Cell Cancer of the Lung
Adenocarcinoma is the most common non-small cell cancer of the lung that occurs in the United States. The majority of these cancers develop in the periphery (outer part) of the lung. Since these cancers are in the outer portion of the lung, the patient often does not have any symptoms when the cancer is found on a chest x-ray. Adenocarcinomas tend to metastasize (spread to other parts of the body) to the bone, the central nervous system (the brain and spinal cord), the adrenal glands, the liver and the opposite lung.
Frequently, there is scarring in adenocarcinomas. Sometimes, the cancer arises in an area of old scarring of the lung. In other cases, the scar appears to arise secondary to the growth of the cancer.
Bronchoalveolar carcinoma or alveolar cell carcinoma is a non-small cell carcinoma that can be found throughout the respiratory tract. When it is discovered as a single mass on a patient’s x-ray, this type of lung cancer has an excellent prognosis. Five year survival after surgery is in the 75-90% range. If, however, it is found in its diffuse form (meaning it has spread beyond a single mass), the prognosis is quite poor.
Squamous cell carcinomas comprise 30-40% of non-small cell carcinomas of the lung. This type of cancer tends to be located in the more central portion of the lung. Often, this is in a bronchus (a large airway of the lung). Since these cancers are located near or in these airways, they can cause symptoms earlier in their growth. Coughing and production of phlegm (sputum) that is bloody are common symptoms. The cancer can block airways which can lead to shortness of breath or pneumonia.
Large cell carcinomas represent about 10% of non-small cell cancers of the lung. This form of lung cancer has fewer structural characteristics when viewed under a microscope. It is sometimes difficult to distinguish this form of lung cancer from cancers which have spread to the lung from another place in the body.
Patient history and diagnosis
53-year-old woman presented in February 2005 with repeated chest infection. A CT scan showed a left lung mass and a soft tissue mass in relation to the left hilum. A biopsy showed consistency with non-small cell lung cancer.
The patient had no breathing difficulties and was commenced on down staging chemotherapy to which she had a partial response, with complete disappearance of left hilar mass and reduction of the apical tumor. Surgery was not possible as the tumor lay close to the pericardium and vital structures, primarily spinal cord. The patient was then referred for radiation therapy.
Non-Small Cell Lung Tumor
Read full IGRT Case Study here
View Images of the Elekta Synergy here
This guide contains information on frequently asked questions and information on the treatment process. While this information will not necessarily correspond to the exact process adopted by an individual hospital, we hope it will provide general background information and an indication of a typical treatment process.
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012Russia’s first Leksell Gamma Knife® Perfexion™ system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow’s Red Square. On June 2, 2011, a 59-year-old woman was the first Perfexion patient, receiving Gamma Knife® radiosurgery to treat tumor tissue that remained following open surgery. Now, eight mon […]
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012N.N. Burdenko Neurosurgical Institute improves treatment of patients with multiple metastasesRead more... […]
- SRT January 31, 2012Würzburg10-11 December - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim26-27 November - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim22-23 November - 2012 […]
- IGRT January 31, 2012Amsterdam16-17 November - 2012 […]
- SBRT January 31, 2012Wake Forest, North Carolina18-19 October - 2012 […]
- IGRT January 31, 2012Amsterdam29-30 June - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim21-22 June - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim18-19 June - 2012 […]